Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 762-767

  Hu, Miao ^a   Lan, Wei ^a   Lam, Christopher W K ^b,c   Mak, Ying Tat ^b   Pang, Chi Pui ^b   Tomlinson, Brian ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Chinese; Coronary heart disease; Familial hypercholesterolemia

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHILD; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORNEA CURVATURE; DISEASE ASSOCIATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOSITY; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; HONG KONG; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PEDIGREE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HOSPITAL; SCHOOL CHILD; SCREENING; SEX RATIO; XANTHOMA;

CHINESE; CORONARY HEART DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HETEROZYGOTE DETECTION; HONG KONG; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84880919889     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.048     Document Type: Article

References (43)

1. A. Yamamoto, T. Kamiya, and T. Yamamura Clinical features of familial hypercholesterolemia Arteriosclerosis 9 1989 I66 I74
2. A.C. Jansen, S. van Wissen, J.C. Defesche, and J.J. Kastelein Phenotypic variability in familial hypercholesterolaemia: an update Curr Opin Lipidol 13 2002 165 171
3. X.M. Sun, D.D. Patel, and J.C. Webb Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype Arterioscler Thromb 14 1994 85 94
4. M. Hu, G.N. Thomas, and B. Tomlinson Lipid disorders in Chinese populations Clin Lipidol 6 2011 549 562
5. F. Farzadfar, M.M. Finucane, and G. Danaei National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants Lancet 377 2011 578 586
6. A. Garg, and V. Simha Update on dyslipidemia J Clin Endocrinol Metab 92 2007 1581 1589
7. T. Noguchi, S. Katsuda, and M.A. Kawashiri The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation Atherosclerosis 210 2010 166 172
8. A.K. Soutar, and R.P. Naoumova Mechanisms of disease: genetic causes of familial hypercholesterolemia Nat Clin Pract Cardiovasc Med 4 2007 214 225
9. D. Sullivan Guidelines for the diagnosis and management of familial hypercholesterolaemia Heart Lung Circ 16 2007 25 27
10. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
11. R.R. Williams, S.C. Hunt, and M.C. Schumacher Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics Am J Cardiol 72 1993 171 176
12. Familial Hypercholesterolaemia (FH) Report of a WHO Consultation: WHO/HGN/CONS/98.7 1998 1 68
13. Y.T. Mak, C.P. Pang, and B. Tomlinson Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients Arterioscler Thromb Vasc Biol 18 1998 1600 1605
14. D. Marks, D. Wonderling, M. Thorogood, H. Lambert, S.E. Humphries, and H.A. Neil Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia BMJ 324 2002 1303
15. A.S. Wierzbicki, S.E. Humphries, and R. Minhas Familial hypercholesterolaemia: summary of NICE guidance BMJ 337 2008 a1095
16. A. Taylor, D. Wang, and K. Patel Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project Clin Genet 77 2010 572 580
17. E.S. van Aalst-Cohen, A.C. Jansen, and M.W. Tanck Diagnosing familial hypercholesterolaemia: the relevance of genetic testing Eur Heart J 27 2006 2240 2246
18. R.W. Pang, S. Tam, and E.D. Janus Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment Atherosclerosis 184 2006 438 445
19. R. Alonso, N. Mata, and S. Castillo Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors Atherosclerosis 200 2008 315 321
20. H. Bujo, K. Takahashi, and Y. Saito Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan J Atheroscler Thromb 11 2004 146 151
21. K.R. Chiou, and M.J. Charng Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia Am J Cardiol 105 2010 1752 1758
22. A.A. Kondkar, K.G. Nair, and T.F. Ashavaid Genetic analysis of Indian subjects with clinical features of possible type IIa hypercholesterolemia J Clin Lab Anal 21 2007 375 381
23. S.N. Pimstone, X.M. Sun, C. du Souich, J.J. Frohlich, M.R. Hayden, and A.K. Soutar Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada Arterioscler Thromb Vasc Biol 18 1998 309 315
24. L. Assouline, E. Levy, J.C. Feoli-Fonseca, C. Godbout, and M. Lambert Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population Pediatrics 96 1995 239 246
25. D. Bhatnagar, J. Morgan, S. Siddiq, M.I. Mackness, J.P. Miller, and P.N. Durrington Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia BMJ 321 2000 1497 1500
26. M.A. Umans-Eckenhausen, J.C. Defesche, E.J. Sijbrands, R.L. Scheerder, and J.J. Kastelein Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands Lancet 357 2001 165 168
27. E.S. Tai, J.M. Ordovas, and D. Corella The TaqIB and - 629C>A polymorphisms at the cholesteryl ester transfer protein locus: associations with lipid levels in a multiethnic population. The 1998 Singapore National Health Survey Clin Genet 63 2003 19 30
28. D.M. Oosterveer, J. Versmissen, M. Yazdanpanah, T.H. Hamza, and E.J. Sijbrands Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis Atherosclerosis 207 2009 311 317
29. D.M. Oosterveer, J. Versmissen, M. Yazdanpanah, J.C. Defesche, J.J. Kastelein, and E.J. Sijbrands The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway Eur Heart J 31 2010 1007 1012
30. D.M. Oosterveer, J. Versmissen, and M. Yazdanpanah 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia Atherosclerosis 206 2009 223 227
31. A. Fernandez, A. Sorokin, and P.D. Thompson Corneal arcus as coronary artery disease risk factor Atherosclerosis 193 2007 235 240
32. S.G. Tsouli, V. Xydis, M.I. Argyropoulou, A.D. Tselepis, M. Elisaf, and D.N. Kiortsis Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study Atherosclerosis 205 2009 151 155
33. M. Christoffersen, R. Frikke-Schmidt, P. Schnohr, G.B. Jensen, B.G. Nordestgaard, and A. Tybjaerg-Hansen Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study BMJ 343 2011 d5497
34. T. Dwyer, S.C. Emmanuel, E.D. Janus, Z. Wu, K.L. Hynes, and C. Zhang The emergence of coronary heart disease in populations of Chinese descent Atherosclerosis 167 2003 303 310
35. A.C. Jansen, E.S. van Aalst-Cohen, and M.W. Tanck The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients J Intern Med 256 2004 482 490
36. J. Critchley, J. Liu, D. Zhao, W. Wei, and S. Capewell Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999 Circulation 110 2004 1236 1244
37. D. Gu, A. Gupta, and P. Muntner Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia) Circulation 112 2005 658 665
38. S.C. Smith Jr., and Z.J. Zheng The impending cardiovascular pandemic in China Circ Cardiovasc Qual Outcomes 3 2010 226 227
39. A. Moran, D. Gu, and D. Zhao Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model - China Circ Cardiovasc Qual Outcomes 3 2010 243 252
40. A. Neil, J. Cooper, and J. Betteridge Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study Eur Heart J 29 2008 2625 2633
41. G.F. Watts, D.R. Sullivan, and N. Poplawski Familial hypercholesterolaemia: a model of care for Australasia Atheroscler Suppl 12 2011 221 263
42. E. Tai, L. Ming Loh, S.K. Sethi, E.S. Koay, Y. Teng Lim, and C. Tan MEDPED comes to Singapore Atherosclerosis 154 2001 252
43. E. Janus The Hong Kong cardiovascular risk factor prevancence study 1995-1996: Hong Kong: Dept of Clinical Biochemistry, Queen Mary Hospital 1997